Press Releases Eli Lilly and Company London S.E.

Equities

LEL

US5324571083

Market Closed - London S.E. Other stock markets 09:37:36 2021-12-10 EST			5-day change	1st Jan Change
225.3 ^CHF	-1.50%		-58.28%	-58.28%

06-26	Augustine Therapeutics N.V. announced that it expects to receive funding from a group of investors	CI
06-25	Top Midday Stories: Microsoft Hit with EU Antitrust Charges; Judge Blocks Swipe-Fee Settlement Between Visa, Mastercard and Retailers; Novo Nordisk Secures Chinese Approval for Weight-Loss Drug; Tesla, Ford Issue Recalls	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases	08:32am	AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round	08:32am	AQ
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria	06-25	PR
Lilly Declares Third-Quarter 2024 Dividend	06-24	PR
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs	06-20	AQ
Eli Lilly and : Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products	06-20	PU
Eli Lilly and : An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®	06-20	PU
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks	06-08	PR
Lilly announces departure of Anat Ashkenazi, chief financial officer	06-05	PR
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality	06-05	AQ
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	06-04	AQ
Eli Lilly and : Asco Lilly Oncology Presentation	06-03	PU
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER	05-31	AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases	05-29	PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	05-29	AQ
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference	05-28	PR
Major manufacturing investment to support API production for tirzepatide	05-27	AQ
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro	05-24	AQ
Eli Lilly and : 2015 Global Health Programs Report	05-24	PU
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines	05-24	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm